Curevac share price logo

Curevac Share Price

NASDAQ: CVAC

$4.66

-0.01

(-0.32%)

as on

Bell Icon

The stock has been delisted from the stock exchange on 5 Jan 2026

Curevac Stock Performance

as on January 6, 2026 at 2:29 am IST

  • Day's Low

    Day's High

    $4.57
    $4.67
    downward going graph

    1.93%

    Downside

    0.21%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.48
    $5.72
    downward going graph

    46.89%

    Downside

    22.75%

    Upside

    downward going graph

Curevac share price movements today

Previous Close
$4.67
Open
$4.63
Volume
1.4M
Day's Low - High
$4.57 - $4.67
52 Week Low - High
$2.48 - $5.72

Curevac Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Curevac Stock Fundamentals & Key Indicators

Check Curevac market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Curevac vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Curevac with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Curevac image
Curevac
BUY$-NANA0.00%
Insmed Incorporated image
Insmed Incorporated
BUY$37.3B414.46%-16.34-264.83%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$52.6B191.54%1243.221.36%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.1B101.11%31.5431.35%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.9B61.38%18.2832.13%

Analyst Recommendation on Curevac Stock

Based on 15 analysts

BUY

66.67%

Buy

26.67%

Hold

6.67%

Sell

Based on 15 analysts, 66.67% of analysts recommend a 'BUY' rating for Curevac. Average target price of $5.38

Curevac Share Price Target

Get share price movements and forecasts by analysts on Curevac.

What analysts predicted

13.38%UPSIDE

Target Price

$5.38

Current Price

$4.66

Analyzed by

15 Analysts

Target

$5.38

Curevac target price $5.38, a slight upside of 13.38% compared to current price of $4.66. According to 15 analysts rating.

Curevac Stock’s Investor Sentiment and Interest

Search interest for Curevac Stock has increased by 142% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:142% versus previous 30 day period

Curevac Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
8
17
24
13
15
548
15
0
1
493
Gross Profit
-19
-8
-33
-31
-28
524
13
0
0
472
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-73
-51
-94
-76
-78
375
-34
-56
-59
338
Net Profit Margin
-889.48%
-295.34%
-383.98%
-570.22%
-502.51%
68.44%
-226.42%
-5832.47%
-4783.94%
68.44%

Curevac Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
14
19
59
116
71
58
559
Gross Profit
-5
-11
42
-152
-123
-77
449
Operating Income
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-81
-110
-156
-465
-263
-283
169
Net Profit Margin
-553.50%
-573.46%
-263.96%
-399.76%
-369.37%
-483.96%
30.30%

Global Institutional Holdings in Curevac

Funds
Holdings
Eckert Corp
0.88%
Qube Research & Technologies
0.53%
BlackRock Inc
0.46%
Freestone Capital Holdings, LLC
0.06%
Jane Street Group LLC
0.06%
See all

Curevac News & Key Events

  • img

    Today's Timeline - 26 November

    Wed, 06:24 PM

    -

    CureVac shareholders overwhelmingly approved proposals for BioNTech's exchange offer at the extraordinary general meeting.

    Thu, 03:28 AM

    -

    BioNTech's exchange offer for CureVac shares approved; expires December 3, 2025, with an exchange ratio of 0.05363 BioNTech ADS per CureVac share.

Insights on Curevac

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -59.56M → 338.04M (in $), with an average increase of 117.6% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 893.0K → 493.90M (in $), with an average increase of 64.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Insmed Incorporated has given 847.0% return, outperforming this stock by 890.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 165.0% return, outperforming this stock by 165.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, CVAC stock has moved down by -9.0%

About Curevac

CureVac NV, formerly CureVac AG, is a Germany-based clinical-stage biopharmaceutical company. The Company develops transformative medicines based on messenger ribonucleic acid, or mRNA. The Company's mRNAs are designed to prevent infections and to treat diseases by mimicking human biology to synthesize the desired proteins. Its technology platform optimizes mRNA constructs that encode functional proteins which either induce a desired immune response or replace defective or missing proteins using the cell’s intrinsic translation machinery. The Company's product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and molecular therapy. In prophylactic vaccines, the Company is advancing its second-generation mRNA backbone against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and a range of infectious diseases, including seasonal influenza, in collaboration with GSK(Glaxo Smith Kline).
OrganisationCurevac
E-voting on sharesClick here to vote

FAQs

What is Curevac share price today?

Curevac share price today is $4.66 as on at the close of the market. Curevac share today touched a day high of $4.67 and a low of $4.57.

What is the 52 week high and 52 week low for Curevac share?

Curevac share touched a 52 week high of $5.72 on and a 52 week low of $2.48 on . Curevac stock price today i.e. is closed at $4.66,which is 18.53% down from its 52 week high and 88.28% up from its 52 week low.

How to invest in Curevac Stock (CVAC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Curevac on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Curevac Shares that will get you 0.3219 shares as per Curevac share price of $4.66 per share as on January 6, 2026 at 2:29 am IST.

What is the minimum amount required to buy Curevac Stock (CVAC) from India?

Indian investors can start investing in Curevac (CVAC) shares with as little as ₹90.143 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹901.43 in Curevac stock (as per the Rupee-Dollar exchange rate as on ). Based on Curevac share’s latest price of $4.66 as on January 6, 2026 at 2:29 am IST, you will get 2.1459 shares of Curevac. Learn more about fractional shares .